Biotechnology
Aeterna Zentaris to Make Oral Presentation on Targeted Inhibitors for PI3K and Erk at Cancer Conference in Berlin
Published in Biotech Business Week, March 28th, 2011
2011 MAR 28 -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") announced that its Senior Director, Head of Preclinical Development, Michael Teifel, Ph.D., will present preclinical results for PI3K/Erk inhibitors AEZS-129, AEZS-131, and AEZS-132, which support further evaluation as potential anticancer compounds. This oral presentation will be made during the Informa Life Sciences Protein Kinases Congress to be held March 22-23, 2011 in Berlin, Germany.
Title:
"Finding novel Kinases targets in oncology at Aeterna Zentaris - Development of inhibitors targeting the MAPK and PI3K pathways"Presenter: Michael Teifel, Ph.D.,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
More Articles from Biotech Business Week
- Advantage Capital Partners
Advantage Capital Partners, Ironwood Capital Invest in Three Innovative Start Up Companies - Biotechnology
BioAmber and CELEXION Announce Exclusive Licensing Partnership - Biotechnology
NIH Director Dr. Francis Collins to Present Keynote Address at Partnering for Global Health Forum 2011 - Taxoids
New Treatment Options Lead to Steady Progress Against Ovarian Cancer; Clinical Trials Remain Imperative - Biotechnology
Start-Up ImmusanT Seeks to Restore Tolerance to Gluten in Celiac Disease with Immunotherapy - Nanotechnology - Molecular Imaging
T2 Biosystems Announces Kirtland Poss as Senior Vice President of Corporate Development - More from this issue of Biotech Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
